Author/Editor | Ećimović, Patricija; Rotovnik-Kozjek, Nada; Janež, Andrej | |
Title | Tumorska hipoglikemija - premalo prepoznano nujno stanje | |
Translated title | Tumor hypoglycemia - under-recognized medical emergency | |
Type | članek | |
Source | Zdrav Vestn | |
Vol. and No. | Letnik 77, št. 3 | |
Publication year | 2008 | |
Volume | str. 219-23 | |
Language | slo | |
Abstract | Background Tumor hypoglycemia is a rare and easily misdiagnosed non-diabetic hypoglycemia that newly arises in a cancer patient. It’s resistant to symptomatic treatment so it is important to investigate for its causes to treat it successfully. Tumor hypoglycemia can be caused by insulinoma, by tumor secretion of insulin-like substances (Insuline-like growth factor 2, IGF-2), liver metastases, cachexia or paraneoplastic endocrine abnormalities. Conclusions We are presenting a review of current literature on tumor hypoglycemia that highlights the importance of investigating causative mechanisms in order to control it. | |
Summary | Izhodišča Tumorska hipoglikemija je redka in zato pogosto spregledana oblika hipoglikemije, ki se na novo pojavi pri bolnikih z rakom. Se ponavlja in je odporna na simptomatsko zdravljenje. Povzročajo jo nevroendokrini tumorji, kot je inzulinom, tumorsko izločanje inzulinu podobne beljakovine (Insuline-like growth factor 2, IGF-2), jetrne metastaze, kaheksija ali pridružene endokrine motnje. Zaključki Za uspešno usmerjeno zdravljenje je ključno prepoznavanje vzroka tumorske hipoglikemije, sicer se hipoglikemične epizode ponavljajo in resno ogrožajo bolnikovo življenje. Predstaviti želimo pregled literature o prepoznavanju in zdravljenju tumorske hipoglikemije. | |
Descriptors | NEOPLASMS HYPOGLYCEMIA INSULIN-LIKE GROWTH FACTOR II INSULINOMA LIVER NEOPLASMS CACHEXIA PARANEOPLASTIC SYNDROMES |